XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Contingent Consideration (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of financial instruments measured at fair value on a recurring basis
The following table summarizes information about the Company’s financial instruments measured at fair value on a recurring basis, grouped into Level 1 to 3 based on the degree to which the input to fair value is observable (in thousands):
March 31, 2023
Level ILevel IILevel IIITotal
DBOT - Contingent consideration1
$— $— $649 $649 
Tree Technology - Contingent consideration2
— — 78 78 
Solectrac - Contingent consideration3
— — 100 100 
VIA - Contingent consideration4
$— $— $60,721 $60,721 
Total$— $— $61,548 $61,548 

December 31, 2022
Level ILevel IILevel IIITotal
DBOT - Contingent consideration1
$— $— $649 $649 
Tree Technology - Contingent consideration2
— — 118 118 
Solectrac - Contingent consideration3
— — $100 100 
Total$— $— $867 $867 

1 This represents the liability incurred in connection with the acquisition of DBOT shares during the three months ended September 30, 2019 and as remeasured as of April 17, 2020. The contractual period which required periodic remeasurement has expired, and therefore the Company will not remeasure this liability in the future. The Company issued 11.3 million shares during the year ended December 31 2020 and still have the obligation to issue 1.0 million shares March 31, 2023 and December 31, 2022.
2 This represents the liability incurred in connection with the acquisition of Tree Technology shares during the three months ended December 31, 2019 and as subsequently remeasured as of March 31, 2023 and 2022. The fair value of the Tree Technology contingent consideration was valued using a probability-weighted discounted cash flow approach.
3 This represents the liability incurred in connection with the acquisition of Solectrac. The liability represents the fair value of the three contingent considerations that were entered into at closing. The fair value was determined using Monte-Carlo simulations.
4 This represents the liability incurred in connection with the acquisition of VIA. The liability represents the fair value of the three contingent considerations that were entered into at closing. The fair value was determined using Monte-Carlo simulations.
Summary of significant inputs and assumptions The following table summarizes the significant inputs and assumptions used in the model:
March 31. 2023 and December 31, 2022
Risk-free interest rate
0.1%
Expected volatility
30%
Expected term (years)
0.08
Expected dividend yield— %
The following table summarizes the significant inputs and assumptions used in the probability-weighted discounted cash flow approach:
March 31, 2023December 31, 2022
Weighted-average cost of capital
15.0%
15.0%
Probability
5%-20%
5%-20%
The following table summarizes the significant inputs and assumptions used in the model:
March 31, 2023 and December 31, 2022
Risk-free interest rate3.4%
Expected volatility25.0%
Expected discount rate13.1%
The following table summarizes the significant inputs and assumptions used in the model:
March 31, 2023
Risk-free interest rate3.7 %
Expected volatility65.0 %
Expected discount rate13.9 %
Schedule of reconciliation of level 3 fair value measurements The following table summarizes the reconciliation of Level 3 fair value measurements (in thousands):
Contingent
Consideration
January 1, 2023$867 
Addition73,628 
Remeasurement loss/(gain) recognized in the statement of operations(12,947)
March 31, 2023$61,548